0000950170-24-092719.txt : 20240807
0000950170-24-092719.hdr.sgml : 20240807
20240807160103
ACCESSION NUMBER: 0000950170-24-092719
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240805
FILED AS OF DATE: 20240807
DATE AS OF CHANGE: 20240807
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Murphy Keith
CENTRAL INDEX KEY: 0001536583
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35996
FILM NUMBER: 241183448
MAIL ADDRESS:
STREET 1: 6275 NANCY RIDGE DRIVE, SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ORGANOVO HOLDINGS, INC.
CENTRAL INDEX KEY: 0001497253
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 271488943
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 11555 SORRENTO VALLEY ROAD
STREET 2: SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-224-1000
MAIL ADDRESS:
STREET 1: 11555 SORRENTO VALLEY ROAD
STREET 2: SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: REAL ESTATE RESTORATION & RENTAL, INC.
DATE OF NAME CHANGE: 20100722
4
1
ownership.xml
4
X0508
4
2024-08-05
0001497253
ORGANOVO HOLDINGS, INC.
ONVO
0001536583
Murphy Keith
11555 SORRENTO VALLEY ROAD
SUITE 100
SAN DIEGO
CA
92121
true
true
false
false
EXECUTIVE CHAIRMAN
false
Common Stock
2024-08-07
4
A
false
19607
0
A
132641
D
Options (right to buy)
0.5368
2024-08-05
4
A
false
574923
0
A
2034-08-05
Common Stock
574923
574923
D
Options (right to buy)
0.5368
2024-08-05
4
A
false
143731
0
A
2034-08-05
Common Stock
143731
143731
D
The reported securities are represented by restricted stock units, which shall vest on the earlier of August 7, 2025 or the date of the annual meeting of stockholders held by the Issuer in 2025, subject to acceleration in the event of a change of control.
The option vests in 3 equal annual installments on each of August 5, 2025, August 5, 2026 and August 5, 2027.
The option becomes exercisable if, after the grant date, the closing sales price of the Common Stock, as reported on the Nasdaq Capital Market (based on a 90-trading day average), is at least $1.53 (subject to adjustment for stock splits), as confirmed by the Board of Directors or a committee thereof.
/s/ Keith Murphy
2024-08-07